APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neprilysin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neprilysin Market Analysis and Forecast 2026-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchNeprilysin Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Neprilysin Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Neprilysin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neprilysin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Neprilysin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Neprilysin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neprilysin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neprilysin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neprilysin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neprilysin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neprilysin include Novartis AG, Theravance Biopharma Inc, Pharmaleads SA and Bioprojet SCR, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neprilysin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neprilysin, also provides the sales of main regions and countries. Of the upcoming market potential for Neprilysin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neprilysin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neprilysin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neprilysin sales, projected growth trends, production technology, application and end-user industry.

Neprilysin Segment by Company

Novartis AG

Theravance Biopharma Inc

Pharmaleads SA

Bioprojet SCR

Neprilysin Segment by Type

TD-0714

STR-324

PL-265

LHW-090

Others

Neprilysin Segment by Application

Acute Heart Failure

Hypertension

Cancer Pain

Alzheimer's Disease

Others

Neprilysin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neprilysin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neprilysin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neprilysin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neprilysin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neprilysin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neprilysin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neprilysin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. TD-0714 Major Manufacturers Table 3. STR-324 Major Manufacturers Table 4. PL-265 Major Manufacturers Table 5. LHW-090 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Neprilysin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Acute Heart Failure Major Manufacturers Table 9. Hypertension Major Manufacturers Table 10. Cancer Pain Major Manufacturers Table 11. Alzheimer's Disease Major Manufacturers Table 12. Others Major Manufacturers Table 13. Neprilysin Industry Trends Table 14. Neprilysin Industry Drivers Table 15. Neprilysin Industry Opportunities and Challenges Table 16. Neprilysin Industry Restraints Table 17. Global Neprilysin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Neprilysin Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Neprilysin Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Neprilysin Revenue Market Share by Region (2021-2026) Table 21. Global Neprilysin Revenue Market Share by Region (2027-2032) Table 22. Global Neprilysin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Neprilysin Sales by Region (2021-2026) & (K Units) Table 24. Global Neprilysin Sales by Region (2027-2032) & (K Units) Table 25. Global Neprilysin Sales Market Share by Region (2021-2026) Table 26. Global Neprilysin Sales Market Share by Region (2027-2032) Table 27. Global Neprilysin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Neprilysin Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Neprilysin Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Neprilysin Sales Market Share by Manufacturers (2021-2026) Table 31. Global Neprilysin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Neprilysin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Neprilysin Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Neprilysin Manufacturers, Product Type & Application Table 35. Global Neprilysin Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Neprilysin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Neprilysin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Neprilysin Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Neprilysin Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Neprilysin Revenue Market Share by Type (2021-2026) Table 42. Global Neprilysin Revenue Market Share by Type (2027-2032) Table 43. Global Neprilysin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Neprilysin Sales by Type (2021-2026) & (K Units) Table 45. Global Neprilysin Sales by Type (2027-2032) & (K Units) Table 46. Global Neprilysin Sales Market Share by Type (2021-2026) Table 47. Global Neprilysin Sales Market Share by Type (2027-2032) Table 48. Global Neprilysin Price by Type (2021-2026) & (US$/Unit) Table 49. Global Neprilysin Price by Type (2027-2032) & (US$/Unit) Table 50. Global Neprilysin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Neprilysin Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Neprilysin Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Neprilysin Revenue Market Share by Application (2021-2026) Table 54. Global Neprilysin Revenue Market Share by Application (2027-2032) Table 55. Global Neprilysin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Neprilysin Sales by Application (2021-2026) & (K Units) Table 57. Global Neprilysin Sales by Application (2027-2032) & (K Units) Table 58. Global Neprilysin Sales Market Share by Application (2021-2026) Table 59. Global Neprilysin Sales Market Share by Application (2027-2032) Table 60. Global Neprilysin Price by Application (2021-2026) & (US$/Unit) Table 61. Global Neprilysin Price by Application (2027-2032) & (US$/Unit) Table 62. Novartis AG Company Information Table 63. Novartis AG Business Overview Table 64. Novartis AG Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novartis AG Neprilysin Product Portfolio Table 66. Novartis AG Recent Development Table 67. Theravance Biopharma Inc Company Information Table 68. Theravance Biopharma Inc Business Overview Table 69. Theravance Biopharma Inc Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Theravance Biopharma Inc Neprilysin Product Portfolio Table 71. Theravance Biopharma Inc Recent Development Table 72. Pharmaleads SA Company Information Table 73. Pharmaleads SA Business Overview Table 74. Pharmaleads SA Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pharmaleads SA Neprilysin Product Portfolio Table 76. Pharmaleads SA Recent Development Table 77. Bioprojet SCR Company Information Table 78. Bioprojet SCR Business Overview Table 79. Bioprojet SCR Neprilysin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bioprojet SCR Neprilysin Product Portfolio Table 81. Bioprojet SCR Recent Development Table 82. North America Neprilysin Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Neprilysin Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Neprilysin Sales by Type (2021-2026) & (K Units) Table 85. North America Neprilysin Sales by Type (2027-2032) & (K Units) Table 86. North America Neprilysin Sales Price by Type (2021-2026) & (US$/Unit) Table 87. North America Neprilysin Sales Price by Type (2027-2032) & (US$/Unit) Table 88. North America Neprilysin Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Neprilysin Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Neprilysin Sales by Application (2021-2026) & (K Units) Table 91. North America Neprilysin Sales by Application (2027-2032) & (K Units) Table 92. North America Neprilysin Sales Price by Application (2021-2026) & (US$/Unit) Table 93. North America Neprilysin Sales Price by Application (2027-2032) & (US$/Unit) Table 94. North America Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Neprilysin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Neprilysin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Neprilysin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 98. North America Neprilysin Sales by Country (2021-2026) & (K Units) Table 99. North America Neprilysin Sales by Country (2027-2032) & (K Units) Table 100. North America Neprilysin Sales Price by Country (2021-2026) & (US$/Unit) Table 101. North America Neprilysin Sales Price by Country (2027-2032) & (US$/Unit) Table 102. United States Neprilysin Revenue (2021-2032) & (US$ Million) Table 103. Canada Neprilysin Revenue (2021-2032) & (US$ Million) Table 104. Europe Neprilysin Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Neprilysin Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Neprilysin Sales by Type (2021-2026) & (K Units) Table 107. Europe Neprilysin Sales by Type (2027-2032) & (K Units) Table 108. Europe Neprilysin Sales Price by Type (2021-2026) & (US$/Unit) Table 109. Europe Neprilysin Sales Price by Type (2027-2032) & (US$/Unit) Table 110. Europe Neprilysin Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Neprilysin Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Neprilysin Sales by Application (2021-2026) & (K Units) Table 113. Europe Neprilysin Sales by Application (2027-2032) & (K Units) Table 114. Europe Neprilysin Sales Price by Application (2021-2026) & (US$/Unit) Table 115. Europe Neprilysin Sales Price by Application (2027-2032) & (US$/Unit) Table 116. Europe Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Neprilysin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Neprilysin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Neprilysin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. Europe Neprilysin Sales by Country (2021-2026) & (K Units) Table 121. Europe Neprilysin Sales by Country (2027-2032) & (K Units) Table 122. Europe Neprilysin Sales Price by Country (2021-2026) & (US$/Unit) Table 123. Europe Neprilysin Sales Price by Country (2027-2032) & (US$/Unit) Table 124. Germany Neprilysin Revenue (2021-2032) & (US$ Million) Table 125. France Neprilysin Revenue (2021-2032) & (US$ Million) Table 126. U.K. Neprilysin Revenue (2021-2032) & (US$ Million) Table 127. Italy Neprilysin Revenue (2021-2032) & (US$ Million) Table 128. Netherlands Neprilysin Revenue (2021-2032) & (US$ Million) Table 129. China Neprilysin Revenue by Type (2021-2026) & (US$ Million) Table 130. China Neprilysin Revenue by Type (2027-2032) & (US$ Million) Table 131. China Neprilysin Sales by Type (2021-2026) & (K Units) Table 132. China Neprilysin Sales by Type (2027-2032) & (K Units) Table 133. China Neprilysin Sales Price by Type (2021-2026) & (US$/Unit) Table 134. China Neprilysin Sales Price by Type (2027-2032) & (US$/Unit) Table 135. China Neprilysin Revenue by Application (2021-2026) & (US$ Million) Table 136. China Neprilysin Revenue by Application (2027-2032) & (US$ Million) Table 137. China Neprilysin Sales by Application (2021-2026) & (K Units) Table 138. China Neprilysin Sales by Application (2027-2032) & (K Units) Table 139. China Neprilysin Sales Price by Application (2021-2026) & (US$/Unit) Table 140. China Neprilysin Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Asia Neprilysin Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Neprilysin Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Neprilysin Sales by Type (2021-2026) & (K Units) Table 144. Asia Neprilysin Sales by Type (2027-2032) & (K Units) Table 145. Asia Neprilysin Sales Price by Type (2021-2026) & (US$/Unit) Table 146. Asia Neprilysin Sales Price by Type (2027-2032) & (US$/Unit) Table 147. Asia Neprilysin Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Neprilysin Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Neprilysin Sales by Application (2021-2026) & (K Units) Table 150. Asia Neprilysin Sales by Application (2027-2032) & (K Units) Table 151. Asia Neprilysin Sales Price by Application (2021-2026) & (US$/Unit) Table 152. Asia Neprilysin Sales Price by Application (2027-2032) & (US$/Unit) Table 153. Asia Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Neprilysin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia Neprilysin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia Neprilysin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. Asia Neprilysin Sales by Country (2021-2026) & (K Units) Table 158. Asia Neprilysin Sales by Country (2027-2032) & (K Units) Table 159. Asia Neprilysin Sales Price by Country (2021-2026) & (US$/Unit) Table 160. Asia Neprilysin Sales Price by Country (2027-2032) & (US$/Unit) Table 161. Japan Neprilysin Revenue (2021-2032) & (US$ Million) Table 162. South Korea Neprilysin Revenue (2021-2032) & (US$ Million) Table 163. India Neprilysin Revenue (2021-2032) & (US$ Million) Table 164. Australia Neprilysin Revenue (2021-2032) & (US$ Million) Table 165. China Taiwan Neprilysin Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia Neprilysin Revenue (2021-2032) & (US$ Million) Table 167. SAMEA Neprilysin Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Neprilysin Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Neprilysin Sales by Type (2021-2026) & (K Units) Table 170. SAMEA Neprilysin Sales by Type (2027-2032) & (K Units) Table 171. SAMEA Neprilysin Sales Price by Type (2021-2026) & (US$/Unit) Table 172. SAMEA Neprilysin Sales Price by Type (2027-2032) & (US$/Unit) Table 173. SAMEA Neprilysin Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA Neprilysin Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA Neprilysin Sales by Application (2021-2026) & (K Units) Table 176. SAMEA Neprilysin Sales by Application (2027-2032) & (K Units) Table 177. SAMEA Neprilysin Sales Price by Application (2021-2026) & (US$/Unit) Table 178. SAMEA Neprilysin Sales Price by Application (2027-2032) & (US$/Unit) Table 179. SAMEA Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA Neprilysin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA Neprilysin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA Neprilysin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 183. SAMEA Neprilysin Sales by Country (2021-2026) & (K Units) Table 184. SAMEA Neprilysin Sales by Country (2027-2032) & (K Units) Table 185. SAMEA Neprilysin Sales Price by Country (2021-2026) & (US$/Unit) Table 186. SAMEA Neprilysin Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Brazil Neprilysin Revenue (2021-2032) & (US$ Million) Table 188. Argentina Neprilysin Revenue (2021-2032) & (US$ Million) Table 189. Chile Neprilysin Revenue (2021-2032) & (US$ Million) Table 190. Colombia Neprilysin Revenue (2021-2032) & (US$ Million) Table 191. Peru Neprilysin Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia Neprilysin Revenue (2021-2032) & (US$ Million) Table 193. Israel Neprilysin Revenue (2021-2032) & (US$ Million) Table 194. UAE Neprilysin Revenue (2021-2032) & (US$ Million) Table 195. Turkey Neprilysin Revenue (2021-2032) & (US$ Million) Table 196. Iran Neprilysin Revenue (2021-2032) & (US$ Million) Table 197. Egypt Neprilysin Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Neprilysin Distributors List Table 201. Neprilysin Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Neprilysin Image Figure 2. Global Neprilysin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neprilysin Market Size Share 2021 VS 2025 VS 2032 Figure 4. TD-0714 Image Figure 5. STR-324 Image Figure 6. PL-265 Image Figure 7. LHW-090 Image Figure 8. Others Image Figure 9. Global Neprilysin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Neprilysin Market Size Share 2021 VS 2025 VS 2032 Figure 11. Acute Heart Failure Image Figure 12. Hypertension Image Figure 13. Cancer Pain Image Figure 14. Alzheimer's Disease Image Figure 15. Others Image Figure 16. Global Neprilysin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Neprilysin Revenue (2021-2032) & (US$ Million) Figure 18. Global Neprilysin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Neprilysin Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Neprilysin Revenue Market Share by Region (2021-2032) Figure 21. Global Neprilysin Sales (2021-2032) & (K Units) Figure 22. Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Neprilysin Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Neprilysin Sales YoY (2021-2032) & (K Units) Figure 25. Europe Neprilysin Sales YoY (2021-2032) & (K Units) Figure 26. China Neprilysin Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Neprilysin Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Neprilysin Sales YoY (2021-2032) & (K Units) Figure 29. Global Neprilysin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Neprilysin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Neprilysin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Neprilysin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Neprilysin Revenue Market Share by Type (2021-2032) Figure 35. Global Neprilysin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Neprilysin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Neprilysin Sales Market Share by Type (2021-2032) Figure 38. Global Neprilysin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Neprilysin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Neprilysin Revenue Market Share by Application (2021-2032) Figure 41. Global Neprilysin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Neprilysin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Neprilysin Sales Market Share by Application (2021-2032) Figure 44. North America Neprilysin Revenue Share by Type (2021-2032) Figure 45. North America Neprilysin Sales Share by Type (2021-2032) Figure 46. North America Neprilysin Revenue Share by Application (2021-2032) Figure 47. North America Neprilysin Sales Share by Application (2021-2032) Figure 48. North America Neprilysin Revenue Share by Country (2021-2032) Figure 49. North America Neprilysin Sales Share by Country (2021-2032) Figure 50. Europe Neprilysin Revenue Share by Type (2021-2032) Figure 51. Europe Neprilysin Sales Share by Type (2021-2032) Figure 52. Europe Neprilysin Revenue Share by Application (2021-2032) Figure 53. Europe Neprilysin Sales Share by Application (2021-2032) Figure 54. Europe Neprilysin Revenue Share by Country (2021-2032) Figure 55. Europe Neprilysin Sales Share by Country (2021-2032) Figure 56. China Neprilysin Revenue Share by Type (2021-2032) Figure 57. China Neprilysin Sales Share by Type (2021-2032) Figure 58. China Neprilysin Revenue Share by Application (2021-2032) Figure 59. China Neprilysin Sales Share by Application (2021-2032) Figure 60. Asia Neprilysin Revenue Share by Type (2021-2032) Figure 61. Asia Neprilysin Sales Share by Type (2021-2032) Figure 62. Asia Neprilysin Revenue Share by Application (2021-2032) Figure 63. Asia Neprilysin Sales Share by Application (2021-2032) Figure 64. Asia Neprilysin Revenue Share by Country (2021-2032) Figure 65. Asia Neprilysin Sales Share by Country (2021-2032) Figure 66. SAMEA Neprilysin Revenue Share by Type (2021-2032) Figure 67. SAMEA Neprilysin Sales Share by Type (2021-2032) Figure 68. SAMEA Neprilysin Revenue Share by Application (2021-2032) Figure 69. SAMEA Neprilysin Sales Share by Application (2021-2032) Figure 70. SAMEA Neprilysin Revenue Share by Country (2021-2032) Figure 71. SAMEA Neprilysin Sales Share by Country (2021-2032) Figure 72. Neprilysin Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Neprilysin Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • TD-0714
  • STR-324
  • PL-265
  • LHW-090
  • Others
Applications
  • Acute Heart Failure
  • Hypertension
  • Cancer Pain
  • Alzheimer's Disease
  • Others
Companies covered
  • Novartis AG
  • Theravance Biopharma Inc
  • Pharmaleads SA
  • Bioprojet SCR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neprilysin Market by Type
  3. 1.2.1 Global Neprilysin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 TD-0714
  5. 1.2.3 STR-324
  6. 1.2.4 PL-265
  7. 1.2.5 LHW-090
  8. 1.2.6 Others
  9. 1.3 Neprilysin Market by Application
  10. 1.3.1 Global Neprilysin Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Acute Heart Failure
  12. 1.3.3 Hypertension
  13. 1.3.4 Cancer Pain
  14. 1.3.5 Alzheimer's Disease
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Neprilysin Market Dynamics
  1. 2.1 Neprilysin Industry Trends
  2. 2.2 Neprilysin Industry Drivers
  3. 2.3 Neprilysin Industry Opportunities and Challenges
  4. 2.4 Neprilysin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neprilysin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neprilysin Revenue by Region
  3. 3.2.1 Global Neprilysin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neprilysin Revenue by Region (2021-2026)
  5. 3.2.3 Global Neprilysin Revenue by Region (2027-2032)
  6. 3.2.4 Global Neprilysin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neprilysin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neprilysin Sales by Region
  9. 3.4.1 Global Neprilysin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neprilysin Sales by Region (2021-2026)
  11. 3.4.3 Global Neprilysin Sales by Region (2027-2032)
  12. 3.4.4 Global Neprilysin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neprilysin Revenue by Manufacturers
  2. 4.1.1 Global Neprilysin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neprilysin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neprilysin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neprilysin Sales by Manufacturers
  6. 4.2.1 Global Neprilysin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neprilysin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neprilysin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neprilysin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neprilysin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neprilysin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neprilysin Manufacturers, Product Type & Application
  13. 4.7 Global Neprilysin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neprilysin Market CR5 and HHI
  16. 4.8.2 2025 Neprilysin Tier 1, Tier 2, and Tier 3
5 Neprilysin Market by Type
  1. 5.1 Global Neprilysin Revenue by Type
  2. 5.1.1 Global Neprilysin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neprilysin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neprilysin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neprilysin Sales by Type
  6. 5.2.1 Global Neprilysin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neprilysin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Neprilysin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neprilysin Price by Type
6 Neprilysin Market by Application
  1. 6.1 Global Neprilysin Revenue by Application
  2. 6.1.1 Global Neprilysin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neprilysin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neprilysin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neprilysin Sales by Application
  6. 6.2.1 Global Neprilysin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neprilysin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Neprilysin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neprilysin Price by Application
7 Company Profiles
  1. 7.1 Novartis AG
  2. 7.1.1 Novartis AG Company Information
  3. 7.1.2 Novartis AG Business Overview
  4. 7.1.3 Novartis AG Neprilysin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis AG Neprilysin Product Portfolio
  6. 7.1.5 Novartis AG Recent Developments
  7. 7.2 Theravance Biopharma Inc
  8. 7.2.1 Theravance Biopharma Inc Company Information
  9. 7.2.2 Theravance Biopharma Inc Business Overview
  10. 7.2.3 Theravance Biopharma Inc Neprilysin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Theravance Biopharma Inc Neprilysin Product Portfolio
  12. 7.2.5 Theravance Biopharma Inc Recent Developments
  13. 7.3 Pharmaleads SA
  14. 7.3.1 Pharmaleads SA Company Information
  15. 7.3.2 Pharmaleads SA Business Overview
  16. 7.3.3 Pharmaleads SA Neprilysin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pharmaleads SA Neprilysin Product Portfolio
  18. 7.3.5 Pharmaleads SA Recent Developments
  19. 7.4 Bioprojet SCR
  20. 7.4.1 Bioprojet SCR Company Information
  21. 7.4.2 Bioprojet SCR Business Overview
  22. 7.4.3 Bioprojet SCR Neprilysin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bioprojet SCR Neprilysin Product Portfolio
  24. 7.4.5 Bioprojet SCR Recent Developments
8 North America
  1. 8.1 North America Neprilysin Market Size by Type
  2. 8.1.1 North America Neprilysin Revenue by Type (2021-2032)
  3. 8.1.2 North America Neprilysin Sales by Type (2021-2032)
  4. 8.1.3 North America Neprilysin Price by Type (2021-2032)
  5. 8.2 North America Neprilysin Market Size by Application
  6. 8.2.1 North America Neprilysin Revenue by Application (2021-2032)
  7. 8.2.2 North America Neprilysin Sales by Application (2021-2032)
  8. 8.2.3 North America Neprilysin Price by Application (2021-2032)
  9. 8.3 North America Neprilysin Market Size by Country
  10. 8.3.1 North America Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neprilysin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neprilysin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Neprilysin Market Size by Type
  2. 9.1.1 Europe Neprilysin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neprilysin Sales by Type (2021-2032)
  4. 9.1.3 Europe Neprilysin Price by Type (2021-2032)
  5. 9.2 Europe Neprilysin Market Size by Application
  6. 9.2.1 Europe Neprilysin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neprilysin Sales by Application (2021-2032)
  8. 9.2.3 Europe Neprilysin Price by Application (2021-2032)
  9. 9.3 Europe Neprilysin Market Size by Country
  10. 9.3.1 Europe Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neprilysin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neprilysin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Neprilysin Market Size by Type
  2. 10.1.1 China Neprilysin Revenue by Type (2021-2032)
  3. 10.1.2 China Neprilysin Sales by Type (2021-2032)
  4. 10.1.3 China Neprilysin Price by Type (2021-2032)
  5. 10.2 China Neprilysin Market Size by Application
  6. 10.2.1 China Neprilysin Revenue by Application (2021-2032)
  7. 10.2.2 China Neprilysin Sales by Application (2021-2032)
  8. 10.2.3 China Neprilysin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neprilysin Market Size by Type
  2. 11.1.1 Asia Neprilysin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neprilysin Sales by Type (2021-2032)
  4. 11.1.3 Asia Neprilysin Price by Type (2021-2032)
  5. 11.2 Asia Neprilysin Market Size by Application
  6. 11.2.1 Asia Neprilysin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neprilysin Sales by Application (2021-2032)
  8. 11.2.3 Asia Neprilysin Price by Application (2021-2032)
  9. 11.3 Asia Neprilysin Market Size by Country
  10. 11.3.1 Asia Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neprilysin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neprilysin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neprilysin Market Size by Type
  2. 12.1.1 SAMEA Neprilysin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neprilysin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neprilysin Price by Type (2021-2032)
  5. 12.2 SAMEA Neprilysin Market Size by Application
  6. 12.2.1 SAMEA Neprilysin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neprilysin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neprilysin Price by Application (2021-2032)
  9. 12.3 SAMEA Neprilysin Market Size by Country
  10. 12.3.1 SAMEA Neprilysin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neprilysin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neprilysin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neprilysin Value Chain Analysis
  2. 13.1.1 Neprilysin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neprilysin Production Mode & Process
  6. 13.2 Neprilysin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neprilysin Distributors
  9. 13.2.3 Neprilysin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst